CTRI/2022/05/042708尚未招募2 期
Double Blind Placebo Controlled Study to Evaluate Efficacy of Innovative Natural Formulation (Sarvonutra M) to Enhance Performance, Endurance Conjugal Life, and Quality of Life in Men
SARVOTHAM CARE LIMITED0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •a) Healthy male individuals.
- •b) Infertility and low conjugal life for more than 3 months diagnosed with oligospermia (defined by <15 million sperms/ml) as per the WHO standards
- •c) No past history of renal, hepatic, or any other chronic illness in the past
- •d) Normal liver, and renal function tests.
- •e) Patients freely willing and able to provide written informed consent, willing to follow study procedures.
排除标准
- •a) Complete azoospermia in the pre-treatment samples
- •b) Any congenital anomaly resulting in oligospermia
- •c) Evidence of male accessory gland infection
- •d) Any recent medical or surgical illness
- •e) Hormone/any other treatment for promoting fertility in the last three months
研究者
相似试验
招募中
2 期
To study efficacy and safety of capsule menoease compared with placebo in women with menopausal symptomsCTRI/2015/02/005585Charak Pharma Pvt Ltd CPP60
招募中
3 期
Does Dexmedetomidine[a sleep inducing drug] prevent injection pain due to Propofol [an anaesthetic drug]?- a studyCTRI/2012/01/002364S N Medical college100
进行中（未招募）
1 期
A clinical trial in patients with type II diabetes with increased risk of cardiovascular events (incidents that may cause damage to the heart muscle), to study how well a person’s diabetes is controlled over a 2-3 month period with bexagliflozin, by measuring blood sugar levels using a HbA1c test, and to determine safety by assessing occurrence of cardiovascular events.Type II diabetesMedDRA version: 21.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 100000004861EUCTR2015-001760-19-NLTheracos Sub, LLC1,650
已完成
3 期
A double blind placebo controlled study to evaluate the effects of bexagliflozin on hemoglobin A1c in patients with type 2 diabetes and increased risk of cardiovascular adverse eventsType 2 diabetes and increased risk of cardiovascular adverse events100192801001842410003216NL-OMON47856Theracos Sub, LLC132
进行中（未招募）
1 期
A clinical trial in patients with type II diabetes with increased risk of cardiovascular events (incidents that may cause damage to the heart muscle), to study how well a person’s diabetes is controlled over a 2-3 month period with bexagliflozin, by measuring blood sugar levels using a HbA1c test, and to determine safety by assessing occurrence of cardiovascular events.Type II diabetesMedDRA version: 20.1 Level: LLT Classification code 10045242 Term: Type II diabetes mellitus System Organ Class: 100000004861EUCTR2015-001760-19-DKTheracos Sub, LLC1,650